{"id":"NCT02279082","sponsor":"Dr. Reddy's Laboratories Limited","briefTitle":"DFN-02 Open Label Safety Study in Patients With Acute Migraine","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-09","primaryCompletion":"2015-09","completion":"2016-03","firstPosted":"2014-10-30","resultsPosted":"2017-08-28","lastUpdate":"2018-03-09"},"enrollment":167,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Acute Migraine"],"interventions":[{"type":"DRUG","name":"DFN-02","otherNames":[]}],"arms":[{"label":"DFN-02","type":"EXPERIMENTAL"}],"summary":"A multi-center, open-label, safety study of DFN-02 for the Treatment of Acute Migraines","primaryOutcome":{"measure":"Number of Participants With Treatment Emergent Adverse Events","timeFrame":"6 months","effectByArm":[{"arm":"DFN-02","deltaMin":120,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":24,"countries":["United States"]},"refs":{"pmids":["27613076","28251391"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":167},"commonTop":["Application site pain","dysgeusia","Upper Respiratory Tract Infection","Nasopharyngitis","Sinusitis"]}}